Pharmacokinetics and Relative Bioavailability of Fixed-Dose Combination of Clopidogrel and Aspirin Versus Co-Administration of Individual Formulations in Healthy Subjects.

Trial Profile

Pharmacokinetics and Relative Bioavailability of Fixed-Dose Combination of Clopidogrel and Aspirin Versus Co-Administration of Individual Formulations in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Mar 2013

At a glance

  • Drugs Aspirin/clopidogrel (Primary) ; Aspirin; Clopidogrel
  • Indications Acute coronary syndromes; Myocardial infarction; Peripheral arterial occlusive disorders; Stroke; Thromboembolism
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Mar 2013 New trial record
    • 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top